サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1400999

肥満細胞腫治療市場：薬剤クラス別、投与経路別、流通経路別、国別、地域別：産業分析、市場規模、市場シェア、2023年～2030年、予測

Mast Cell Tumors Treatment Market, By Drug Class, By Route of Administration, By Distribution Channel, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030

出版日
ページ情報
英文 79 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.28円
肥満細胞腫治療市場：薬剤クラス別、投与経路別、流通経路別、国別、地域別：産業分析、市場規模、市場シェア、2023年～2030年、予測
出版日: 2023年12月17日
発行: AnalystView Market Insights
ページ情報: 英文 79 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

肥満細胞腫治療市場規模は2022年に51億米ドルと評価され、2023年から2030年にかけてCAGR 3.6%で拡大

肥満細胞腫治療市場 - 市場力学

獣医腫瘍学における精密医療重視の高まりが市場需要を促進

肥満細胞腫の発生と進行に寄与する遺伝的・分子的メカニズムに関する知識が向上するにつれて、標的療法がますます可能になります。この個別化された方法は、腫瘍の個々の特徴に合わせて医薬品を調整し、悪影響を最小限に抑えながら効果を最大化します。革新的な標的治療薬や免疫療法の開発は、個々の腫瘍の遺伝子解析や分子解析によって牽引されています。この推進力は、治療結果だけでなく、肥満細胞腫やその他の悪性腫瘍に苦しむ犬たちの生活の質全体を向上させる。

肥満細胞腫治療市場 - 主要洞察

弊社のリサーチアナリストの分析によれば、世界の肥満細胞腫治療市場は予測期間（2023年～2030年）において約3.6%のCAGRで毎年成長すると予測されています。

肥満細胞腫治療産業は、獣医腫瘍学における精密医療への重点の高まりにより、著しい速度で成長すると予測されています。

薬剤クラス別では、エピネフリンが2022年に最大市場シェアを示すと予測されています。

投与経路別では、2022年には注射剤が薬剤クラス別でトップに

地域別では、アジア太平洋地域が2022年の売上高をリードしています。

肥満細胞腫治療市場 - セグメンテーション分析：

肥満細胞腫治療の世界市場は薬剤クラス別、投与経路別、流通チャネル別、地域別に区分されます。

薬剤クラス別に市場は4つに分類される：抗ヒスタミン薬、エピネフリン、ステロイド、肥満細胞安定剤です。市場を独占しているのはエピネフリンです。MCTにはヒスタミンを産生する能力があり、状況によっては重篤なアレルギー反応を引き起こす可能性があるため、治療中にエピネフリンが必要になることがあります。エピネフリンは緊急薬として、MCTの脱顆粒によって引き起こされるアナフィラキシー反応の管理に役立ち、より迅速な介入と患者の転帰改善を可能にします。

市場は投与経路によって3つのカテゴリーに分けられる：経口剤、注射剤、局所剤です。注射剤が市場を独占しており、予測期間中もその優位性は維持されるであろう。注射剤は、様々な理由から肥満細胞腫の治療に高い需要があります。注射薬は、化学療法、標的治療、および肥満細胞腫の脱顆粒によって引き起こされる重篤なアレルギー反応の状況におけるエピネフリンのような緊急薬の投与に使用され、この難しいタイプのがんの治療を成功させ、迅速に行うことができます。

肥満細胞腫治療市場 - 地理的洞察

地理的に、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカの各地域に広がっています。これらの地域は、ビジネスをもたらす国によってさらに分けられます。犬の肥満細胞腫（MCT）はアジア太平洋地域で人気が高まっています。この傾向は様々なことが影響しています。この地域のいくつかの国ではペットの飼育率が上昇しており、獣医師のサービスや治療に対する市場が急成長しています。第二に、犬の健康問題、特にMCTのようながんに関する知識の増加により、より多くの飼い主がペットの治療を求めるようになった。最後に、アジア太平洋地域における獣医腫瘍学の進歩や専門的な動物病院やクリニックの増加により、診断や治療の選択肢が増え、効果的なMCT治療に対する同地域の高まるニーズに応えています。

肥満細胞腫治療市場 - 競合情勢：

肥満細胞腫（MCT）の治療状況はダイナミックであり、様々な要素が作用しています。Zoetis社、Elanco社、Merck Animal Health社などの大手動物用製薬会社からは、化学療法や標的治療薬が発売されています。さらに、高度な放射線療法は、PetCure cancerのような専門の獣医がんセンターで受けることができます。新薬の開発を目標とした研究開発は、環境に影響を与える可能性があります。製薬会社、研究機関、動物病院間の協力は、MCT療法の進歩を促進します。ペットヘルスケアへの注目が高まる中、競合が治療法の改善を促進し、最終的には犬のMCT患者とその家族を支援することになります。

目次

第1章 肥満細胞腫瘍治療市場概要

  • 調査範囲
  • 市場推定年数

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 肥満細胞腫瘍治療の主要な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 今後の市場動向

第4章 肥満細胞腫瘍治療産業の調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しのマッピング
  • 規制枠組みの分析

第5章 肥満細胞腫瘍治療市場：COVID-19感染症の影響分析

  • 新型コロナウイルス感染症以前の影響分析
  • 新型コロナウイルス感染症後の影響分析

第6章 肥満細胞腫瘍治療市場情勢

  • 肥満細胞腫瘍治療市場シェア分析、2022年
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 肥満細胞腫瘍治療市場 - 薬剤クラス別

  • 概要
    • 薬剤クラス別のセグメントシェア分析
    • 抗ヒスタミン薬
    • エピネフリン
    • ステロイド
    • マスト細胞安定剤

第8章 肥満細胞腫瘍治療市場 - 投与経路別

  • 概要
    • 投与経路別セグメントシェア分析
    • 経口
    • 注射
    • 局所

第9章 肥満細胞腫瘍治療市場 - 流通チャネル別

  • 概要
    • 販売チャネル別のセグメントシェア分析
    • 病院薬局
    • 小売薬局
    • ドラッグストア
    • オンライン薬局

第10章 肥満細胞腫瘍治療市場 - 地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析 - 肥満細胞腫瘍治療産業

  • 競合ダッシュボード
  • 企業プロファイル
    • Zoetis
    • Elanco Animal Health
    • Merck Animal Health
    • Boehringer Ingelheim
    • PetCure Oncology
    • Varian Medical Systems
    • VetDC, Inc.
    • Oasmia Pharmaceutical AB
    • Aratana Therapeutics
    • Rhizen Pharmaceuticals
    • Animal Medical Center
    • Blue Buffalo Foundation
    • Ethos Veterinary Health
    • PetCure Oncology
    • Veterinary Cancer Group

第12章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data Route of Administrations
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Mast Cell Tumors Treatment Market: Drug Class Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Drug Class
  • TABLE Global Mast Cell Tumors Treatment Market, by Drug Class 2018-2030 (USD Million)
  • TABLE Mast Cell Tumors Treatment Market: Route of Administration Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Route of Administration
  • TABLE Global Mast Cell Tumors Treatment Market, by Route of Administration 2018-2030 (USD Million)
  • TABLE Mast Cell Tumors Treatment Market: Distribution Channel Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Distribution Channel
  • TABLE Global Mast Cell Tumors Treatment Market, by Distribution Channel 2018-2030 (USD Million)
  • TABLE Mast Cell Tumors Treatment Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Mast Cell Tumors Treatment Market, by Region 2018-2030 (USD Million)
  • TABLE North America Mast Cell Tumors Treatment Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Mast Cell Tumors Treatment Market, by Drug Class, 2018-2030 (USD Million)
  • TABLE North America Mast Cell Tumors Treatment Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE North America Mast Cell Tumors Treatment Market, by Distribution Channel, 2018-2030 (USD Million)
  • TABLE Europe Mast Cell Tumors Treatment Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Mast Cell Tumors Treatment Market, by Drug Class, 2018-2030 (USD Million)
  • TABLE Europe Mast Cell Tumors Treatment Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Europe Mast Cell Tumors Treatment Market, by Distribution Channel, 2018-2030 (USD Million)
  • TABLE Asia Pacific Mast Cell Tumors Treatment Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Mast Cell Tumors Treatment Market, by Drug Class, 2018-2030 (USD Million)
  • TABLE Asia Pacific Mast Cell Tumors Treatment Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Asia Pacific Mast Cell Tumors Treatment Market, by Distribution Channel, 2018-2030 (USD Million)
  • TABLE Latin America Mast Cell Tumors Treatment Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Mast Cell Tumors Treatment Market, by Drug Class, 2018-2030 (USD Million)
  • TABLE Latin America Mast Cell Tumors Treatment Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Latin America Mast Cell Tumors Treatment Market, by Distribution Channel, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Mast Cell Tumors Treatment Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Mast Cell Tumors Treatment Market, by Drug Class, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Mast Cell Tumors Treatment Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Mast Cell Tumors Treatment Market, by Distribution Channel, 2018-2030 (USD Million)
目次
Product Code: ANV1963

REPORT HIGHLIGHT

Mast Cell Tumors Treatment Market size was valued at USD 5,100 Million in 2022, expanding at a CAGR of 3.6% from 2023 to 2030.

Mast cell tumors (MCTs) are a kind of cancer that is frequent in dogs. Mast cells, a kind of immune cell implicated in allergic responses and inflammation, are the source of these tumors. MCTs come in a variety of sizes, shapes, and malignancies. Mast cell tumors are normally treated surgically, with the goal of entirely excising the tumor. Additional treatments, such as radiation, chemotherapy, or targeted drugs, may be required in certain circumstances, particularly for aggressive or metastatic tumors. Regular veterinarian check-ups and monitoring are essential for dogs at risk of MCTs since early discovery and timely treatment are critical for a favorable outcome.

Mast Cell Tumors Treatment Market- Market Dynamics

Increasing emphasis on precision medicine in veterinary oncology propel market demand

Targeted therapy becomes increasingly possible as knowledge of the genetic and molecular mechanisms that contribute to MCT genesis and progression improves. This personalized method tailor's medicines to the tumor's individual features, maximizing effectiveness while minimizing negative effects. The development of innovative targeted medications and immunotherapies is gaining traction, led by genetic and molecular analysis of individual tumours. This driver improves not just treatment results but also the entire quality of life for dogs suffering from MCTs and other malignancies.

Mast Cell Tumors Treatment Market- Key Insights

As per the analysis shared by our research analyst, the global Mast Cell Tumors Treatment market is estimated to grow annually at a CAGR of around 3.6% over the forecast period (2023-2030)

The Mast Cell Tumors Treatment industry is projected to grow at a significant rate due to increasing emphasis on precision medicine in veterinary oncology.

Based on Drug Class segmentation, Epinephrine was predicted to show maximum market share in the year 2022

Based on Route of Administration segmentation, Injectables was the leading Drug Class in 2022

On the basis of region, Asia Pacific was the leading revenue generator in 2022

Mast Cell Tumors Treatment Market- Segmentation Analysis:

The Global Mast Cell Tumors Treatment Market is segmented on the basis of Drug Class, Route of Administration, Distribution Channel, and Region.

The market is divided into four categories based on Drug Class: Antihistamines, Epinephrine, Steroids, Mast-cell stabilizers. The Epinephrine dominates the market. Because MCTs have the ability to produce histamines, which may cause severe allergic responses in certain circumstances, epinephrine need may occur during therapy. As an emergency medication, epinephrine aids in the management of anaphylactic responses caused by MCT degranulation, allowing for faster intervention and better patient outcomes.

The market is divided into three categories based on Route of Administration: Oral, Injectables, Topical. The Injectables sector dominates the market and is likely to maintain its dominance during the forecast period. Injectable medicines are in high demand for the treatment of mast cell tumors for a variety of reasons. They are used to deliver chemotherapy, targeted treatments, and emergency medications like as epinephrine in situations of severe allergic responses induced by MCT degranulation, providing successful and speedy treatment of this difficult type of cancer.

Mast Cell Tumors Treatment Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. Mast cell tumors (MCTs) in dogs are becoming more popular in the Asia-Pacific area. This tendency is influenced by a variety of things. Increased pet ownership rates in several nations around the area have resulted in a burgeoning market for veterinarian services and treatments. Second, increased knowledge of canine health issues, particularly cancers such as MCTs, has prompted more pet owners to seek medical attention for their pets. Finally, advances in veterinary oncology and an increasing number of specialized veterinary clinics and hospitals in the Asia-Pacific area have enhanced access to diagnostic and treatment choices, satisfying the region's growing need for effective MCT treatments.

Mast Cell Tumors Treatment Market- Competitive Landscape:

The therapy landscape for mast cell tumors (MCTs) is dynamic, with various elements at work. Chemotherapy and targeted medicines are available from leading veterinary pharmaceutical firms such as Zoetis, Elanco, and Merck Animal Health. Furthermore, sophisticated radiation therapy are available at specialized veterinary cancer centers such as PetCure cancer. Research and development initiatives targeted at developing novel medicines can have an impact on the environment. Collaboration among pharmaceutical firms, research institutions, and veterinary clinics promotes MCT therapy advancement. With a rising focus on pet healthcare, competition promotes therapeutic improvements, eventually helping canine MCT sufferers and their families.

Recent Developments:

In May 2023, Sensus Healthcare Inc., a leading provider of sophisticated medical devices for non-surgical skin cancer and keloid scar treatment, is pleased to announce that their superficial radiation therapy SRT-100 system has shown encouraging results in treating Cutaneous Mast Cell Tumours (MCTs) in cats. This new restricted research, which recently appeared in the Journal of the American Veterinary Medical Association, shows the potential efficacy and safety of SRT therapy.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL MAST CELL TUMORS TREATMENT MARKET KEY PLAYERS

  • Zoetis
  • Elanco Animal Health
  • Merck Animal Health
  • Boehringer Ingelheim
  • PetCure Oncology
  • Varian Medical Systems
  • VetDC, Inc.
  • Oasmia Pharmaceutical AB
  • Aratana Therapeutics
  • Rhizen Pharmaceuticals
  • Animal Medical Center
  • Blue Buffalo Foundation
  • Ethos Veterinary Health
  • PetCure Oncology
  • Veterinary Cancer Group

GLOBAL MAST CELL TUMORS TREATMENT MARKET, BY DRUG CLASS

  • Antihistamines
  • Epinephrine
  • Steroids
  • Mast-cell stabilizers

GLOBAL MAST CELL TUMORS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION

  • Oral
  • Injectables
  • Topical

GLOBAL MAST CELL TUMORS TREATMENT MARKET, BY DISTRIBUTION CHANNEL

  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug Stores
  • Online Pharmacies

GLOBAL MAST CELL TUMORS TREATMENT MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Mast Cell Tumors Treatment Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Mast Cell Tumors Treatment Market Snippet by Drug Class
    • 2.1.2. Mast Cell Tumors Treatment Market Snippet by Route of Administration
    • 2.1.3. Mast Cell Tumors Treatment Market Snippet by Distribution Channel
    • 2.1.4. Mast Cell Tumors Treatment Market Snippet by Country
    • 2.1.5. Mast Cell Tumors Treatment Market Snippet by Region
  • 2.2. Competitive Insights

3. Mast Cell Tumors Treatment Key Market Trends

  • 3.1. Mast Cell Tumors Treatment Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Mast Cell Tumors Treatment Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Mast Cell Tumors Treatment Market Opportunities
  • 3.4. Mast Cell Tumors Treatment Market Future Trends

4. Mast Cell Tumors Treatment Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Mast Cell Tumors Treatment Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Mast Cell Tumors Treatment Market Landscape

  • 6.1. Mast Cell Tumors Treatment Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Mast Cell Tumors Treatment Market - By Drug Class

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Drug Class, 2022 & 2030 (%)
    • 7.1.2. Antihistamines
    • 7.1.3. Epinephrine
    • 7.1.4. Steroids
    • 7.1.5. Mast-cell stabilizers

8. Mast Cell Tumors Treatment Market - By Route of Administration

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Route of Administration, 2022 & 2030 (%)
    • 8.1.2. Oral
    • 8.1.3. Injectables
    • 8.1.4. Topical

9. Mast Cell Tumors Treatment Market - By Distribution Channel

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Distribution Channel, 2022 & 2030 (%)
    • 9.1.2. Hospital Pharmacies
    • 9.1.3. Retail Pharmacies
    • 9.1.4. Drug Stores
    • 9.1.5. Online Pharmacies

10. Mast Cell Tumors Treatment Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Mast Cell Tumors Treatment Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Mast Cell Tumors Treatment Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Mast Cell Tumors Treatment Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Mast Cell Tumors Treatment Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Mast Cell Tumors Treatment Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Mast Cell Tumors Treatment Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Zoetis
    • 11.2.2. Elanco Animal Health
    • 11.2.3. Merck Animal Health
    • 11.2.4. Boehringer Ingelheim
    • 11.2.5. PetCure Oncology
    • 11.2.6. Varian Medical Systems
    • 11.2.7. VetDC, Inc.
    • 11.2.8. Oasmia Pharmaceutical AB
    • 11.2.9. Aratana Therapeutics
    • 11.2.10. Rhizen Pharmaceuticals
    • 11.2.11. Animal Medical Center
    • 11.2.12. Blue Buffalo Foundation
    • 11.2.13. Ethos Veterinary Health
    • 11.2.14. PetCure Oncology
    • 11.2.15. Veterinary Cancer Group

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us